King's College London receives charitable donation from Parkinson's UK to begin a first-of-its-kind clinical trial to study the effects of CBD on psychosis symptoms in patients with early-stage Parkinson's disease. Parkinson's UK, Europe's largest charitable institution for Parkinson's research, announced this week that they will be funding the first-ever clinical trial to determine if cannabidiol (CBD) is a safe and effective treatment for symptoms of psychosis associated with the disease. Th...
Browse Article Categories
CBD for Symptoms of Psychosis in Parkinson's Patients
Rate this article
No Comments Yet
Be the first to share what you think!